Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Mental health

How to stop nightmares, according to a sleep expert

What are nightmares, what causes them and how can you make them stop? Sleep experts answer.

Tom’s Guide

Finger-prick test could diagnose early Alzheimer's with 'needle in a hay stack' precision

Test detects biomarkers of condition before symptoms progress

Evening Standard

Type 2 diabetes drug associated with 35% lower risk of dementia, study finds

Large Korean study suggests sodium-glucose cotransporter-2 inhibitors, may lower the risk of dementia

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Drugs used to treat type 2 diabetes linked to lower dementia risk – study

Researchers said trials are needed to confirm their findings.

The Independent UK

Diabetes drug ‘may lower risk of developing dementia’

Huge potential for research into drugs that can be repurposed to treat dementia and Alzheimer’s, say experts

The Independent UK

I did MDMA therapy before it was legal. For me it was transformative – but I have some concerns

I didn’t think I would ever break the law to try alternative medicine. But as Australia finds itself at the forefront of the therapy, I’m in a unique position

The Guardian - AU

How might a digital detox impact our brains?

Taking time away from our phones can help reset our minds.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

London's noise wars: unacceptable or just part of city living? The rows over the capital's cacophony

Whether you struggle with loud neighbours or think the buzz of a city is what makes it great, there’s no denying that everyone has an opinion when it comes to the sound of London.

Evening Standard

How to Plan Ahead After a Loved One's Dementia Diagnosis

Financial, medical and safety preparations can ease the burden for caregivers while ensuring your loved one receives their preferred care.

Kiplinger

How to calm anxiety at night naturally, according to a sleep doctor

Why we suffer from nighttime anxiety, plus how to ease it naturally according to sleep experts.

Tom’s Guide

Florida says execution shouldn't be stayed for Parkinson's symptoms

Attorneys for the state of Florida say the execution of a man with Parkinson’s symptoms should not be delayed

The Independent UK

Knowing your blood pressure could save your life

Hypertension is the silent killer – and Australians have been ignoring the catastrophic consequences

The Guardian - AU

Study finds new gene in progression of Huntington's disease

Berlin : A novel gene has been linked by researchers in Berlin and Dusseldorf to the development of Huntington's disease in a brain organoid model. Earlier than previously believed, the gene may play a role in brain disorders. Read further on Dynamite News:

Dynamite News

People Living With Brain Aneurysm At High Risk Of Anxiety, Depression: Study

Being aware of the aneurysm diagnosis was linked to a 10% higher risk of a mental health condition such as anxiety, stress, depression, eating disorders, bipolar disorder, insomnia, and alcohol or drug misuse.

Medical Daily

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

‘I remember crying walking into school’: having anxiety as a child

Two young people talk about their mental health experiences and how important getting support was

The Guardian - UK

‘It’s as if he got away with it’: how the law prevented Lucy getting justice for child sexual abuse

‘Lucy’ was groomed by a friend’s father, who admitted he had sex with her when she was 14, but could not be charged

Salon

The backlash to Gus Walz's bullies

Neurodiversity and disability rights advocates condemned the bullying of Gus Walz for being emotional

The Independent UK

What are the symptoms and treatments for Alzheimer’s – as new drug is rejected

Lecanemab has been deamed too expensive for use on the NHS.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

UK drug regulator approves Alzheimer's drug but government likely won't pay for it

Britain’s drug regulator has authorized the Alzheimer’s drug Leqembi, saying that it’s the first medicine to show some impact in slowing progression of the neurodegenerative disease

Evening Standard

East London student who was carer for blind parents gets top GCSE results

Cother Nada Toba, 16, from Forest Gate, said she wanted to ‘make my parents proud’

The Independent UK

What you need to know about lecanemab – the Alzheimer’s drug rejected for NHS use

The drug has been developed by Eisai, a Japanese pharmaceutical company, and is sold under the brand name Leqembi

Evening Standard

What is Lecanemab and who makes it? Alzheimer’s drug gets approval but will not be available on the NHS

NICE says drug is not cost effective and shares fears of side effects

The Independent UK

First drug to slow Alzheimer’s progression will not be made available on the NHS

The spending watchdog has recommended that a drug shown to slow the progression of Alzheimer’s disease should not be rolled out on the NHS.

The Guardian - UK

UK health regulator rejects lecanemab as treatment for Alzheimer’s

Decision by Nice to rule out drug being available on NHS comes despite medicines licensing body giving green light

Evening Standard

OPINION - What you think you know about sleep is almost certainly wrong

Sleep is like shoe size: one size does not fit all. Sleep has become yet another aspect of our lives that makes us anxious. Advice about sleep often resembles the commands of a regimental sergeant major. I frequently read “you must get eight hours of sleep” or “waking up in…

1 … 42 43 44 45

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Alzheimer Research UK

The Medicines and Healthcare products Regulatory Agency

13 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.